Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis

Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described. Medical charts were retrospectively reviewed for all cases of culture-confirmed, INH-monoresistant tuberculosis ( n = 137) reported to the San Francisco Departmen...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical infectious diseases Ročník 48; číslo 2; s. 179
Hlavní autoři:	Cattamanchi, Adithya, Dantes, Raymund B, Metcalfe, John Z, Jarlsberg, Leah G, Grinsdale, Jennifer, Kawamura, L Masae, Osmond, Dennis, Hopewell, Philip C, Nahid, Payam
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 15.01.2009
Témata:	Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Drug Resistance, Bacterial Female Humans Isoniazid - pharmacology Male Middle Aged Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - isolation & purification Pyrazinamide - adverse effects Pyrazinamide - therapeutic use San Francisco Treatment Outcome Tuberculosis - drug therapy Tuberculosis - microbiology Tuberculosis - physiopathology San Francisco
ISSN:	1537-6591, 1537-6591
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!